ProPublica

Journalism in the Public Interest

Cancel

Doctor Payments on the Decline

Pharmaceutical company payments to health care professionals dropped between 2011 and 2012 among most of the companies and categories ProPublica tracks, driven in part by increased transparency as well as blockbuster drugs losing patent protection. Research payments, however, have increased among that group. Search: Has Your Health Professional Received Drug Company Money?


Source: ProPublica research, based on pharmaceutical company disclosures. Note: The totals for AstraZeneca, Eli Lilly, Forest, GlaxoSmithKline, Johnson & Johnson, Valeant and ViiV combine payments from several disclosure reports and may not match their report totals displayed in some places in Dollars for Docs.